Search

everythinglearnresearchcommunity

for

Search:↓

PRP shows promise for treating female hair loss but needs more research.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Understanding hair health and disorders is important for effective treatment.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Long-term breastfeeding and preterm labor may worsen postpartum hair loss.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Trichoscopy helps diagnose and manage different types of hair loss in the Indian population.

Adding a zygomaticotemporal nerve block reduces pain more effectively during hair regrowth treatments.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Skin changes like dryness and hair loss can signal hypothyroidism before tests confirm it.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The study found increased skin pigmentation and variable melanocyte density in a patient with Addison's disease.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Most patients with hair loss sought treatment for cosmetic reasons, were unhappy about their appearance, and had a family history of the condition, suggesting it may be inherited.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.